Translating clinical research of Molecular Biology into a personalized, multidisciplinary approach of colorectal cancer patients.

J Med Life · 2014 · PMC3956090 · PMID 24653752

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

[ 73 ] showed that patients whose CRC harbored BRAF mutation showed no response to anti- EGFR therapy, and they also showed a negative trend for both time to progression and survival.

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.